Adma Biologics Inc

ADMANASDAQ · USD
9.11USD0.00 (+1.79%)
845

Adma Biologics Inc (ADMA) Implied Volatility Current

ADMA implied volatility is 49%. IV Rank is 9%, placing current premiums in the bottom of their 52-week range.

Read more

Tracking ADMA implied volatility helps you identify when options premiums on Adma Biologics Inc are historically cheap or expensive, and where the best trades are hiding. Adma Biologics Inc implied volatility reflects the market's expectation of future price movement: when ADMA IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Adma Biologics Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For ADMA, tracking metrics like ADMA IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on ADMA signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. The company also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S.

pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where ADMA implied volatility sits today versus where it has been. Our scanner ranks Adma Biologics Inc implied volatility against its historical range, surfaces extremes in ADMA IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Adma Biologics Inc IV is rich or cheap — measure it, then act on it.

Implied Volatility

IV Rank
9.13%IV Rank
Low

IV is compressed vs the past year - options are relatively cheap, favoring buyers.

Implied Volatility (30d)49.43%

IV Rank9.13%

Historical Volatility (30d)35.15%

IV - HV+14.28%

As of September 18, 2026

Trade options with IV on your side

Track ADMA IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.

Start your 14-day free trial